triaging_pdl1_3d_requests
This is an old revision of the document!
Table of Contents
Biomarker Index (Quick Reference)
PDL1UPPERGIMARCH2026: PD-L1 IHC (22C3) for Gastric, GEJ, and Esophageal Adenocarcinoma/ESCC BMCLAUDIN18: Claudin 18.2 IHC for Gastric or GEJ Adenocarcinoma PDL1HNSCC22C3PEMBRO: PD-L1 IHC (22C3) for Advanced HNSCC PDL1HNSCCNEOADPEMBRO: PD-L1 IHC (22C3) for Resectable HNSCC (Neoadjuvant) PDL1CERVIX: PD-L1 IHC (22C3) for Cervical Cancer (SCC/Adeno) MOLARCEP17: CEP17 SISH Ploidy Analysis PDL1NSCLCPEMBRO22C3: PD-L1 IHC (22C3) for NSCLC Stage IIIb to IV PDL1NSCLCATEZOSP263: PD-L1 IHC (SP263) for NSCLC Stage II to IIIA (Adjuvant) PDL1TNBC22C3PEMBRO: PD-L1 IHC (22C3) for Triple Negative Breast Cancer
—
Detailed Biomarker Tables
Gastrointestinal Biomarkers
| Biomarker | Assay Purpose | Drug(s) | Diagnostic Test | Test ID |
|---|---|---|---|---|
| PD-L1 | Gastric, GEJ, esophageal adenocarcinoma; ESCC | Pembrolizumab, Nivolumab | PDL1 Dako 22C3 PharmDX | ''PDL1UPPERGIMARCH2026'' |
| Claudin 18.2 | Gastric or GEJ adenocarcinoma | Zolbetuximab | VENTANA CLDN18 (43-14A) RxDx | ''BMCLAUDIN18'' |
Head & Neck Biomarkers
| Biomarker | Assay Purpose | Drug(s) | Diagnostic Test | Test ID |
|---|---|---|---|---|
| PD-L1 | Advanced HNSCC | Pembrolizumab | PDL1 Dako 22C3 PharmDX | ''PDL1HNSCC22C3PEMBRO'' |
| PD-L1 | Resectable HNSCC | Pembrolizumab as Neoadjuvant | PDL1 Dako 22C3 PharmDX | ''PDL1HNSCCNEOADPEMBRO'' |
Gyne Biomarkers
| Biomarker | Assay Purpose | Drug(s) | Diagnostic Test | Test ID |
|---|---|---|---|---|
| PD-L1 | Cervical cancer (SCC and Adenocarcinoma) | Pembrolizumab | PDL1 Dako 22C3 PharmDX | ''PDL1CERVIX'' |
| CEP17 SISH | Ploidy Analysis | N/A | VENTANA Inform Chromosome 17 probe | ''MOLARCEP17'' |
Lung Biomarkers
| Biomarker | Assay Purpose | Drug(s) | Diagnostic Test | Test ID |
|---|---|---|---|---|
| PD-L1 | NSCLC stage IIIb to IV | Pembrolizumab | PDL1 22C3 | ''PDL1NSCLCPEMBRO22C3'' |
| PD-L1 | NSCLC stage II to IIIA | Atezolizumab as Adjuvant | PDL1 SP263 | ''PDL1NSCLCATEZOSP263'' |
Breast Biomarkers
| Biomarker | Assay Purpose | Drug(s) | Diagnostic Test | Test ID |
|---|---|---|---|---|
| PD-L1 | Triple Negative Breast Cancer (TNBC) | Pembrolizumab | PDL1 Dako 22C3 PharmDX | ''PDL1TNBC22C3PEMBRO'' |
triaging_pdl1_3d_requests.1775593718.txt.gz · Last modified: by gilbert